1000 Participants Needed

Safety Planning + Interpersonal Therapy for Suicide Prevention

Recruiting at 6 trial locations
HC
DS
TR
Overseen ByTaylor Ryan, MA
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores two treatments to help prevent suicide in adolescents. The Stanley Brown Safety Planning Intervention and Follow-up Contacts (SPI+) involves creating a personalized safety plan to manage suicidal thoughts and crises. Interpersonal Psychotherapy for Adolescents Ultra Short Crisis Intervention (IPT-A SCI) is a therapy that aims to improve relationships and reduce depression. The trial seeks to determine which method works better for young people visiting emergency departments due to suicidal thoughts or actions. It is suitable for English or Spanish-speaking teens aged 12-19 who have recently visited the hospital for suicide-related issues and have a phone for follow-up. As an unphased trial, this study offers participants a unique opportunity to contribute to important research that could enhance mental health interventions for adolescents.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that these interventions are safe for suicidal adolescents?

Research has shown that both treatments under study are generally safe for teenagers. Previous studies have found the Interpersonal Psychotherapy for Adolescents Ultra Short Crisis Intervention (IPT-A SCI) to be safe, practical, and acceptable. Early results with small groups of teens have been promising, encouraging further research.

The Stanley Brown Safety Planning Intervention (SPI+) is also considered safe. It offers a brief, evidence-based method to lower suicide risk, with structured follow-up to help keep individuals safe. This approach is designed for people who have faced suicidal crises and involves creating personalized safety plans.

Both treatments aim to reduce the risk of suicide and help young people handle crises. While data on negative effects is limited, existing research suggests that both interventions are generally well-tolerated.12345

Why are researchers excited about this trial?

Researchers are excited about these treatments because they offer innovative approaches to suicide prevention in adolescents. Unlike traditional therapies, which often require extended periods to see results, the Ultra-Short Crisis Intervention (IPT-A SCI) is designed to be scalable and flexible, providing quicker support to reduce depressive symptoms and improve interpersonal relationships. The Safety Planning Intervention (SPI+) stands out by empowering at-risk youths with personalized, step-by-step plans to manage suicidal thoughts, including follow-up contacts for ongoing support. These treatments aim to directly address interpersonal issues and crisis management, which are key factors in suicidal behavior among young people.

What evidence suggests that this trial's treatments could be effective for suicide prevention in adolescents?

Research has shown that the Interpersonal Psychotherapy for Adolescents Ultra Short Crisis Intervention (IPT-A SCI), one of the treatments in this trial, is as effective as standard treatments in reducing suicidal thoughts, depression, and anxiety in children and teens. Early study results have been promising in lowering suicidal thoughts and depression in young people.

The Stanley Brown Safety Planning Intervention and Follow-up Contacts (SPI+), another treatment option in this trial, nearly halved the chances of suicidal behavior over six months. It offers a simple, personalized plan with steps to follow during a suicidal crisis, helping to manage and reduce risk. Both treatments provide practical, evidence-based support for at-risk youth.12467

Who Is on the Research Team?

HC

Holly C Wilcox, PhD

Principal Investigator

Johns Hopkins Bloomberg School of Public Health

Are You a Good Fit for This Trial?

This trial is for diverse high-risk youth aged 12-19 who have visited acute care for suicide-related concerns or screened positive for suicidal thoughts or attempts in the past month. Participants must have a cell phone and be able to communicate in English or Spanish.

Inclusion Criteria

I've had a recent acute care visit for suicide concerns or scored high on a suicide risk test.
I've had thoughts of suicide or attempted it in the last four weeks.
I have a cell phone that can make calls and receive texts for the next year.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either the Stanley Brown Safety Planning Intervention and Follow-up Contacts (SPI+) or Interpersonal Psychotherapy for Adolescents Ultra Short Crisis Intervention (IPT-A SCI) to prevent suicidal crises.

12 weeks
Weekly sessions

Follow-up

Participants are monitored for changes in suicidal behavior, quality of life, anxiety, and depression.

12 months
Assessments at baseline, 3 months, 6 months, and 12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Interpersonal Psychotherapy for Adolescents Ultra Short Crisis Intervention (IPT-A SCI)
  • Stanley Brown Safety Planning Intervention and Follow-up Contacts (SPI+)
Trial Overview The study compares two interventions: SPI+, which helps prevent escalation of suicidal crises, and IPT-A SCI, a psychotherapy that teaches skills to avoid such crises and tackles interpersonal issues leading to them. It aims to set future care standards for at-risk youth.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Ultra-Brief Crisis IPT-AActive Control1 Intervention
Group II: Safety Planning InterventionActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

Johns Hopkins All Children's Hospital

Collaborator

Trials
47
Recruited
5,009,000+

Children's Hospital of Philadelphia

Collaborator

Trials
749
Recruited
11,400,000+

Columbia University

Collaborator

Trials
1,529
Recruited
2,832,000+

Research Foundation for Mental Hygiene, Inc.

Collaborator

Trials
68
Recruited
21,100+

Reichman University, Israel

Collaborator

Trials
1
Recruited
1,000+

Johns Hopkins All Childrens Hospital

Collaborator

Trials
1
Recruited
1,000+

Childrens Hospital of Philadelphia

Collaborator

Trials
1
Recruited
1,000+

Reichman University

Collaborator

Published Research Related to This Trial

The Safety Planning Intervention (SPI) is effective in reducing suicidal ideation and behavior, as well as improving depression and treatment engagement among adults experiencing suicide-related distress, based on a systematic review of 26 studies.
The SPI is adaptable and can be delivered in various formats (in-person or online) and as a standalone or combined intervention, making it a flexible tool in suicide prevention practices.
The Effectiveness of the Safety Planning Intervention for Adults Experiencing Suicide-Related Distress: A Systematic Review.Ferguson, M., Rhodes, K., Loughhead, M., et al.[2022]
The Safety Planning Intervention (SPI) is a structured six-step action plan designed to help individuals at risk of suicide by enhancing their coping strategies and social support, and by removing access to means of self-harm.
Research shows that SPI is highly effective in reducing suicidal behavior, making it a valuable tool in various settings such as emergency rooms and outpatient clinics.
[SAFETY PLANNING INTERVENTION FOR SUICIDE PREVENTION].Perlstein, J., Katzir, N., Lotan, A., et al.[2022]
A meta-analysis of 6 studies involving 3536 participants found that safety planning-type interventions (SPTIs) significantly reduce suicidal behavior, with a relative risk of 0.570 compared to control groups, indicating they are effective in preventing suicide attempts.
However, the same analysis showed no significant effect of SPTIs on reducing suicidal ideation, suggesting that while SPTIs are beneficial for preventing actions, additional strategies may be necessary to address thoughts of suicide.
Safety planning-type interventions for suicide prevention: meta-analysis.Nuij, C., van Ballegooijen, W., de Beurs, D., et al.[2022]

Citations

Ultra-Brief Crisis IPT-A Based Intervention for Suicidal ...The treatment appears to be safe, feasible and acceptable and initial results show promising trends to support further study of the approach.
NCT06151158 | Preventing Suicidal Behavior With Diverse ...The study will compare the effectiveness of two relatively brief and scalable evidence-based interventions: the SPI+, a suicide-specific intervention that helps ...
Comparative Effectiveness of Ultra-Brief, IPT-A Based ...IPT-A-SCI is feasible and as effective as the standard treatment in reducing suicidal, depressive, and anxiety symptoms among children and adolescents.
Comparative Effectiveness of Ultra-Brief, IPT-A Based ...IPT-A-SCI is feasible and as effective as the standard treatment in reducing suicidal, depressive, and anxiety symptoms among children and adolescents.
(PDF) Ultra-Brief Crisis IPT-A Based Intervention for ...Preliminary Results from our samples of 26 adolescents indicate meaningful trends for both the suicidal ideation (SIQ) and depression (MFQ) ...
Ultra-brief crisis interpersonal psychotherapy based ...The intervention has four main objectives: first, a focused treatment for reducing suicide risk; second, a short and immediate response; third, building a ...
Suicide Prevention in Youth | Current Psychiatry ReportsA comparative effectiveness trial of a brief suicide crisis intervention based on Interpersonal Psychotherapy for Adolescents (IPT-A-SCI) ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security